Unilife is included in Cantor Fitzgeralds Global Equity Research Best Ideas 2014. It is the only company in the Medical Devices and Dianostics Sector. The target price for the end of 2014 is $8
UNS Price at posting:
83.0¢ Sentiment: Buy Disclosure: Held